|
One-year Outcomes Of Photodynamic Therapy
One-Year Outcomes of Photodynamic Therapy in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy in Japanese Patients.
Author: Gomi F , Ohji M , Sayanagi K , Sawa M , Sakaguchi H , Oshima Y , Ikuno Y , Tano Y
Source: Ophthalmology, (): 0 2007
Summary of Research:
The purpose of the study was to determine the prevalence of polypoidal choroidal vasculopathy (PCV) in Japanese patients presumed to have age-related macular degeneration (AMD) and compare 1-year outcomes after photodynamic therapy between PCV and choroidal neovascularization secondary to AMD.
How the researchers designed the study:
Prospective interventional study.
The people who took part in this study:
Ninety-three consecutive patients (93 eyes) met the inclusion criteria: at least 50 years old, best-corrected visual acuity (VA) of 34 to 73 on the Early Treatment Diabetic Retinopathy Study (ETDRS) letter chart, a subfoveal lesion 5400 mum or smaller in greatest linear dimension (GLD) on fluorescein angiography (FA), and eligibility for photodynamic therapy.
The methods used in the research:
Indocyanine green angiography was performed in all participants, and PCV and AMD were differentiated, treated with photodynamic therapy, and the patients observed for 1 year. The GLD was determined by FA for AMD and by indocyanine green angiography for PCV,
LASIK: Revolutionising correction of refractive errors
LASIK, an unprecedented advancement in eye care, offers people a safe and simple opportunity to see the world clearly, minus the inconvenience or discomfort of scratched or lost contact lenses, or the blocked side vision of spectacles. In simple term LASIK is a revolutionary laser technique for correction of refractive errors.
LASIK surgery works wonders for Packers' Ferguson
Ferguson said he went to three doctors seeking a panacea for the headaches. One suggested that LASIK surgery probably would solve his eye problem and just might curb the headaches.
New, Improved LASIK Surgery
Just how much better this new ?wavefront-guided LASIK? works isn't proven yet, but it's causing excitement among eye surgeons who say the three-dimensional maps let them customize treatment in a way never before possible.
Opening Your Eyes To LASIK
More and more people are going under the laser to shed their glasses and contact lenses. So the Eye Surgery Education Council has issued new guidelines to help patients determine whether they could be candidates for laser eye surgery.
BLADE-FREE LASIK SURGERY
Are you near-sighted? Far-sighted? LASIK eye surgery could rid you of your glasses. But if fear of going under the blade is stopping you -- stop worrying. Now, a new blade-free approach.
and the diameter of the laser spot size was chosen, with an extra 1000 mum added to the GLD. Photodynamic therapy was repeated if leakage occurred on FA at 3-month follow-up visits.
How the researchers measured the outcome:
Prevalence of PCV at baseline and visual and angiographic changes 1 year after photodynamic therapy in PCV and AMD.
Results & Conclusion:
Using indocyanine green angiography, 36 eyes (39%) were diagnosed with PCV and 54 eyes (58%) with choroidal neovascularization secondary to AMD. The median change in VA using the ETDRS letter score from baseline to 1 year was -7.0 in AMD eyes and +8.0 in PCV eyes (Mann-Whitney rank sum test; P<0.001). The VA improved (>/=15 letters) in AMD and PCV by 6% and 25%, respectively, and decreased (>/=15 letters) by 31% and 8%, respectively. Fluorescein leakage stopped at 1 year in 86% of PCV and 61% of AMD eyes (P = 0.031). Polypoidal choroidal vasculopathy recurred in 2 PCV eyes (5.6%), and a new PCV lesion developed in 1 PCV eye (2.8%) and 2 AMD eyes (3.7%) on indocyanine green angiography at 1 year.
The researchers concluded:
The prevalence of PCV meeting the treatment criteria for photodynamic therapy for presumed AMD is high in Japanese patients. Photodynamic therapy is more efficacious for PCV than for AMD, which may explain the good results in Japanese patients. Further study should assess the long-term clinical results.
|
